SavedAdd your journal

Journals / Ağrı / 2021 / Cilt: 33 - Sayı: 3

The long-term effects of plasma disc coagulation therapy for cervical disc hernia

Servikal disk hernisinde plazma disk koagülasyon tedavisinin uzun dönem etkileri

Ahmet Kürşad POYRAZ
Sibel ÖZCAN
Serhat TAŞKIN
Arzu MUZ
Selami Ateş ÖNAL
Journal
Ağrı
Pages
176–182
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The initial mean VAS score was6.5±0.9, and it decreased to 3.4±0.2 on the final follow-up (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Recently, plasma disc coagulation therapy (PDCT) has been used in the treatment of lumbar and cervical dischernia (CDH), but the long-term effects of PDCT have not been well documented.
📊
Key Findings & Data:The patients demographicsand pain scores [visual analog scale (VAS)] were recorded on the baseline and in the 1st, 3rd, 6th, and 12th months after PDCTtreatment.
💡
Conclusion & Impact:The initial mean VAS score was6.5±0.9, and it decreased to 3.4±0.2 on the final follow-up (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Recently, plasma disc coagulation therapy (PDCT) has been used in the treatment of lumbar and cervical dischernia (CDH), but the long-term effects of PDCT have not been well documented. The aim of this study was to assess the longtermeffects of PDCT on pain score, disc volume, and patient satisfaction in patients with CDH.Methods: Eighty patients with CDH, who underwent PDCT treatment, were included in the study. The patients demographicsand pain scores [visual analog scale (VAS)] were recorded on the baseline and in the 1st, 3rd, 6th, and 12th months after PDCTtreatment. We evaluated patient satisfaction and disc volume on the 12th month after PDCT.Results: A statistically significant and time-dependent decrease was determined in VAS score. The initial mean VAS score was6.5±0.9, and it decreased to 3.4±0.2 on the final follow-up (p

Özet

Amaç: Son zamanlarda, lomber ve servikal disk hernisi (SDH) tedavisinde plazma disk koagülasyon tedavisi (PDCT) kullanılmıştır, ancak PDCT’ nin uzun dönem etkileri tam olarak belgelenmemiştir. Bu çalışmanın amacı, servikal disk hernili hastalarda PDCT’ nin ağrı skoru, disk hacmi ve hasta memnuniyeti üzerindeki uzun dönem etkilerini değerlendirmektir. Gereç ve Yöntem: PDCT tedavisi uygulanan 80 SDH hastası çalışmaya alındı. Hastaların demografik özellikleri ve ağrı skorları (görsel analog skala-VAS) başlangıçta ve PDCT tedavisinden sonraki 1., 3., 6. ve 12. aylarda kaydedildi. PDCT’den sonraki 12. ayda hasta memnuniyeti ve disk hacmi değerlendirildi. Bulgular: VAS skorunda zaman bağımlı ve istatistiksel olarak anlamlı azalma saptandı. Başlangıçtaki VAS skoru 6.5±0.9 iken, son takipte 3.4±0.2 olarak tespit edildi (p

🔖

Cite This Article

POYRAZ, A. K., ÖZCAN, S., TAŞKIN, S., MUZ, A., ÖNAL, S. A. (2022). The long-term effects of plasma disc coagulation therapy for cervical disc hernia. Ağrı, Cilt: 33 - Sayı: 3, 176–182. https://ajindex.com/articles/430567

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Corniola MV, Tessitore E, Schaller K, Gautschi OP. Cervical disc herniation-diagnosis and treatment. Rev Med Suisse 2015
  2. 11(492):2023–9. [CrossRef ] 2. Kloth DS, Calodney AK, Derby R, Lagattuta FP, O’Neill C, Yurth E, et al. Improving the safety of transforaminal epidural steroid injections in the treatment of cervical radiculopathy. Pain Physician 2011
  3. 14(3):285–93. [CrossRef ] 3. Mansfield M, Smith T, Spahr N, Thacker M. Cervical spine radiculopathy epidemiology: A systematic review. Musculoskeletal Care 2020
  4. 18(4):555–67. [CrossRef ] 4. Gebremariam L, Koes BW, Peul WC, Huisstede BM. Evaluation of treatment effectiveness for the herniated cervical disc: A systematic review. Spine (Phila Pa 1976) 2012
  5. 37(2):109–18. [CrossRef ] 5. Nasser R, Yadla S, Maltenfort MG, Harrop JS, Anderson DG, Vaccaro AR, et al. Complications in spine surgery. J Neurosurg Spine 2010
  6. 13(2):144–57. [CrossRef ] 6. Harada J, Dohi M, Fukuda K, Nakazaki H, Koyama T, Abe T. CTguided percutaneous laser disk decompression (PLDD) for cervical disk hernia. Radiat Med 2001
  7. 19(5):263–6. 7. Romero-Rangel JA, Soriano-Solís S, Rodríguez-García M, Soto-García ME, Soriano-Solís H, Aranda-Torres BY, et al. Dysphagia rates after minimally invasive tubular approach to the anterior cervical spine. Cir Cir 2020
  8. 88(3):286–91. 8. Kelekis AD, Filippiadis DK, Martin JB, Brountzos E. Standards of practice: Quality assurance guidelines for percutaneous treatments of intervertebral discs. Cardiovasc Intervent Radiol 2010
  9. 33(5):909–13. [CrossRef ] 9. Alo KM, Wright RE, Sutcliffe J, Brandt SA. Percutaneous lumbar discectomy: One-year follow-up in an initial cohort of fifty consecutive patients with chronic radicular pain. Pain Pract 2005
  10. 5(2):116–24. [CrossRef ] 10. Filippiadis DK, Kelekis A. A review of percutaneous techniques for low back pain and neuralgia: Current trends in epidural infiltrations, intervertebral disk and facet joint therapies. Br J Radiol 2016
  11. 89(1057):20150357. [CrossRef ] 11. Zhao XL, Fu ZJ, Xu YG, Zhao XJ, Song WG, Zheng H. Treatment of lumbar intervertebral disc herniation using C-arm fluoroscopy guided target percutaneous laser disc decompression. Photomed Laser Surg 2012
  12. 30(2):92–5. [CrossRef ] 12. Kim SH, Kim SC, Cho KH. Clinical outcomes of percutaneous plasma disc coagulation therapy for lumbar herniated disc diseases. J Korean Neurosurg Soc 2012
  13. 51(1):8–13. 13. Zini C, Notaro D, Sadotti G, Zini G, Monti L, Bellini M. Percutaneous intervertebral disc coagulation therapy (PDCT)